Acasti Pharma Awarded Notice of Allowance for Second Composition of Matter Patent in Canada Apr 20, 2020
Acasti Pharma Submits FDA Meeting Request on Schedule, and FDA Meeting Expected in the Second Half of June Apr 1, 2020
Acasti Pharma Awarded Notice of Allowance for Additional Composition of Matter and Method of Use Patents in the United States and Mexico Mar 11, 2020
Acasti Pharma Provides Update on Timing of Topline Results for TRILOGY 1 Phase 3 Trial of CaPre Dec 23, 2019
